Journal Watch - Sucroferric Oxyhydroxide
Iron-based Binder Safe and Effective in PD
A study conducted with 84 PD patients compared sucroferric oxyhydroxide (n=56) to sevelamer (n=28). After a year, both groups had serum phosphate levels within the target range. The iron-based binder required fewer pills per day and resulted in fewer adverse events. Read the abstract.
Read the abstract » | (added 11/13/2017)